Earnings remain strong with solid return on capital Nolato

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Earnings remain strong with solid return on capital

Nolato reports sustained strong earnings and a solid return on capital in its Q3 2013 interim report released today. Group sales rose by 12% to SEK 1,119 million (999), with operating profit (EBITA) up 23% to SEK 103 million (84). Earnings per share for the past 12-month period rose to SEK 11.25 (6.70). “We’re very pleased indeed that our strong performance continued in the third quarter,” says President and CEO of Nolato, Hans Porat. Sales of the Nolato Medical business area rose 8% to SEK 310 million (288), which was well in line with market growth. Operating profit (EBITA) increased to SEK 41 million (32), and the EBITA margin rose to 13.2% (11.1). “Most of the business area’s customer segments enjoyed solid volumes,” says Hans Porat. “The margin was positively affected by a favourable product mix.” Sales of the Nolato Telecom business area rose 16% to SEK 516 million (444). Operating profit (EBITA) totalled SEK 35 million (35), with an EBITA margin of 6.8% (7.9). “The gradual renewal of the product portfolio in the second half of the year, with a slightly higher proportion of materials, affected the margin,” comments Hans Porat. Sales of the Nolato Industrial business area rose 9% to SEK 293 million (268). Operating profit (EBITA) climbed to SEK 33 million (24), and the EBITA margin to a very strong 11.3% (9.0). “Volumes were stable and during the holiday period, there was higher demand this year than in the same period last year. Combined with high productivity and a favourable product mix, this gave a positive effect on the margin,” says Hans Porat. Nolato’s Board resolved at its meeting today on the extension of the Hungarian factory by a further 3,700 square metres in order to enable further future expansion. Nolato’s financial position remains strong. Return on capital employed for the past 12-month period was 25.5% (17.8). Net debt stood at SEK 75 million (323), with an equity/assets ratio of 45% (43). The year-end report for 2013 will be released on 4 February 2014. The AGM will be held on 28 April 2014. --------- For further information, please contact: Hans Porat, President and CEO, +46 (0)705 517550 Per-Ola Holmström, CFO, +46 (0)705 763340 Nolato is a high-tech developer and manufacturer of polymer products for leading customers in medical technology, telecommunications, hygiene, automotive and other selected industrial sectors. Its B shares are listed on the NASDAQ OMX Stockholm. Nolato is a Mid Cap company in the Industrials sector. www.nolato.com The information is such which Nolato AB is obliged to disclose under the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. This information was made public on 24 October 2013 at 2.30 pm.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Explosive Growth in AI and Privacy Tokens Boosts Market

Updated Category News Views 199

Market Momentum and Emerging Trends in AI and Privacy Tokens Recently, the global crypto market found itself amidst a wave of activity, highlighted by the resurgence of the AI and privacy sectors. Despite facing volatility, these niche markets have captured the attention of investors and traders, resulting in vibrant trading on platforms like HTX. This surge reflects not...

Continue Reading
Banzai Welcomes Dean Ditto as New CFO Amid Growth Charge

Updated Category News Views 185

Banzai Welcomes New Chief Financial Officer Banzai International, Inc. (NASDAQ: BNZI), a prominent player in marketing technology, has announced the exciting appointment of Dean Ditto as its new Chief Financial Officer. This strategic move, which marks a significant development in the company’s management, is aimed at enhancing its financial operations and overall...

Continue Reading
Cybin Inc. Announces Share Consolidation to Enhance Structure

Updated Category News Views 245

Cybin Inc. Announces Share Consolidation Cybin Inc. (NYSE American: CYBN) (Cboe CA:CYBN), a key player in neuropsychiatry focused on innovative treatments, has taken a significant step by consolidating its common shares. Starting immediately, every 38 existing shares have been combined into a single new share, which notably decreases the total number of shares available....

Continue Reading
Voreifarem and SwfcNrho Exchange: Innovating Medical Data Space

Updated Category News Views 301

Voreifarem Partners with SwfcNrho Exchange In an exciting development for the digital health sector, Voreifarem has officially launched its trading on the popular compliant platform, SwfcNrho. Known for being the first digital health project utilizing the combination of medical chips and blockchain technology, Voreifarem is making waves with its token IER. This recent...

Continue Reading
ez1095 ACA Software 2025: Boost Your Filing Efficiency

Updated Category News Views 129

ez1095 ACA Software 2025: Enhance Your Filing Experience The latest ez1095 software from Halfpricesoft.com includes a cutting-edge network edition that enables organizations to file ACA forms to the IRS from multiple locations. This feature is especially vital as companies continue to embrace remote work and flexible operational structures. Key Features of ez1095 Software...

Continue Reading